Who Will Benefit from the Darunavir Single-Tablet Regimen for HIV?

Video

Magda Opsomer, MD, reveals who will benefit from the darunavir single-tablet HIV regimen.

Magda Opsomer, MD, director and clinical leader of Infectious Diseases and Vaccines at Janssen Pharmaceutical Companies, Belgium, reveals who will benefit from the darunavir single-tablet HIV regimen.

Related Videos
A panel of 4 experts on HIV
A panel of 4 experts on HIV
© 2024 MJH Life Sciences

All rights reserved.